本品能特异性作用于胃壁细胞质子泵H+-K+-ATP酶所在部位,抑制壁细胞泌酸的最后步骤,使壁细胞内的H+不能转运到胃腔中去,使胃液中胃酸量减少。本品吸收快,1小时内起效,0.5~3.5小时血药浓度达峰值,作用持续72小时以上。 C 动物实验未发现有致畸作用,但有致癌作用。在人类,本品是否有致畸作用尚无充分的研究报道,但认为其不是主要的致畸剂。因此,最安全的做法是在妊娠期,特别是前3个月,尽可能地不用本品。妊娠和授乳期大鼠给予35~345倍人体剂量的本品,能够导致幼鼠体重增加减少,但在临床上未见乳儿有这种情况。本品在动物中有致癌作用,并可能抑制乳儿的胃酸分泌,因此哺乳期最好不用本品。 [1]Ruigomez A,Garcia Rodriguez LA,Cat aruzzi C,et al.Use of cimeti dine,omeprazole,and ranitidine in pregnant women and pregnancy out comes.Am J Epidemiol,1999,150∶476 [2]Marshal JK,Thompson AB,Armstrong D.Omeprazole for refractory gastroesophageal reflux disease during pregnancy and lactation.Can J Gastroenterol,1998,12∶225 [3]Nikfar S,Abdol ahi M,Moret i ME,et al.Use of proton pump inhibi tors during pregnancy and rates of major malformations:a meta-analysis. Dig Dis Sci,2002,47∶1526 [4]Kal en BA.Use of omeprazole during pregnancy-no hazard demonstrated in 955 infants exposed during pregnancy.Eur J Obstet Gynecol Reprod Biol,2001,96∶63-68 [5]Briggs GG,Freeman RK,Yaf e SJ.Drugs in Pregnancy and Lactation. 6th edition,Baltimore:Wil iams &Wilkins,2001,1033
……